OC-0608 Phase II trial of hypofractionated postoperative radiotherapy in prostate cancer: NCT02192788. (May 2022) - Hervás, A.; Zapatero, A.; Carballo, A.M.; Barrado, M.; López-Campos, F.; Cano, C.; Martin de Vidales, C.; Rodríguez, A.; Eito, C.; Salinas, A.; Peleteiro, P.; Visus, I.; et al.